fluorescein-5-isothiocyanate has been researched along with Airway Hyper-Responsiveness in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gorman, S; Hart, PH; McGonigle, TA; Ng, RL; Scott, NM | 1 |
Dearman, RJ; Humphreys, N; Kimber, I; Skinner, RA | 1 |
Akhter, SR; Gao, XP; Rubinstein, I | 1 |
3 other study(ies) available for fluorescein-5-isothiocyanate and Airway Hyper-Responsiveness
Article | Year |
---|---|
Reduced immune responses in chimeric mice engrafted with bone marrow cells from mice with airways inflammation.
Topics: Administration, Intranasal; Adoptive Transfer; Animals; Azacitidine; Bone Marrow Cells; Bronchoalveolar Lavage Fluid; Cell Count; Decitabine; Dendritic Cells; Disease Models, Animal; DNA Modification Methylases; Female; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Immunoglobulin E; Immunoglobulin G; Inflammation; Lipopolysaccharides; Lymph Nodes; Mice, Inbred C57BL; Organic Chemicals; Ovalbumin; Radiation Chimera; Respiratory Hypersensitivity; Skin | 2015 |
Allergen-induced cytokine phenotypes in mice: role of CD4 and CD8 T cell populations.
Topics: Allergens; Animals; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cytokines; Dinitrochlorobenzene; Female; Fluorescein-5-isothiocyanate; Formaldehyde; Interferon-gamma; Interleukin-4; Lymphocyte Count; Mice; Mice, Inbred BALB C; Phenotype; Phthalic Anhydrides; Respiratory Hypersensitivity | 2005 |
Ovalbumin increases macromolecular efflux from the in situ nasal mucosa of allergic hamsters.
Topics: Adenosine; Animals; Arginine; Bradykinin; Bradykinin Receptor Antagonists; Cricetinae; Dextrans; Enzyme Inhibitors; Exudates and Transudates; Fluorescein-5-isothiocyanate; Male; Mesocricetus; Nasal Decongestants; Nasal Mucosa; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Ovalbumin; Phenylephrine; Respiratory Hypersensitivity; Serine Proteinase Inhibitors; Vasodilator Agents | 1998 |